<DOC>
	<DOCNO>NCT02486627</DOCNO>
	<brief_summary>This randomize , multicenter , multinational , double-blind study compare efficacy safety plazomicin compare meropenem follow optional oral ( PO ) therapy treatment cUTI , include AP , adult .</brief_summary>
	<brief_title>A Study Plazomicin Compared With Meropenem Treatment Complicated Urinary Tract Infection ( cUTI ) Including Acute Pyelonephritis ( AP )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Pyelonephritis</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Key Pyuria Have pretreatment baseline urine culture obtain within 36 hour start administration first dose study drug Clinical sign and/or symptom acute pyelonephritis complicate urinary tract infection Normal renal function moderate renal impairment Key Confirmed fungal urinary tract infection time randomization Known urinary tract infection colonization Grampositive pathogens Current cUTI AP know cause pathogen resistant meropenem Female patient childbearing potential know pregnant positive pregnancy test screening , breastfeeding , unable unwilling use highly effective method birth control study least 30 day follow last dose study medication Any rapidly progress disease immediately lifethreatening illness Documented presence immunodeficiency immunocompromised condition Documented known history otologic surgery disease include use hearing aid , head injury lead otologic damage , Ménière 's disease , tumor head , neck , auditory system , perilymphatic fistula , autoimmune disease inner ear , family history hearing loss ( exclude agerelated hearing loss [ onset age 65 year ] )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cUTI</keyword>
	<keyword>AP</keyword>
	<keyword>ACHN-490</keyword>
	<keyword>anti-infective</keyword>
	<keyword>anti-bacterial</keyword>
	<keyword>antibiotic</keyword>
	<keyword>anti-microbial</keyword>
	<keyword>UTI</keyword>
	<keyword>bacterial infection</keyword>
	<keyword>Gram-negative</keyword>
</DOC>